ASO Author Reflections: Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Surgical Conversion in Borderline Resectable Cholangiocarcinoma. - Dong Y; Starlinger P (Annals of surgical oncology, 2025)